ClinicalTrials.Veeva

Menu

the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients

C

Central Hospital, Nancy, France

Status

Unknown

Conditions

Cholangiocarcinoma

Treatments

Other: early palliative care

Study type

Observational

Funder types

Other

Identifiers

NCT04415190
2019PI274

Details and patient eligibility

About

The prognosis for cholangiocarcinoma is bad. Potentially, early management by a palliative care team could increase overall survival. We will also assess whether early management by a palliative care team could impact progression-free survival, the place of death and the date of the last chemotherapy, in particular to avoid unnecessary chemotherapy cures in an imminent end of life

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age> 18 years old
  • intra- or extra-hepatic CCK or histologically proven vesicular adenocarcinoma
  • Locally advanced and / or metastatic disease from the start or recurrent
  • Initial diagnosis or recurrence between 1/01/2013 and 31/12/2019

Exclusion criteria

  • <18 years old
  • death less than one week after the diagnostic

Trial design

150 participants in 2 patient groups

cholangiocarcinoma with early palliative care
Treatment:
Other: early palliative care
cholangiocarcinoma without early palliative care

Trial contacts and locations

1

Loading...

Central trial contact

Anthony Lopez

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems